SS
KRYS icon

SBI Securities’s Krystal Biotech KRYS Stock Holding History

SBI Securities’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.7K Buy
123
+54
+78% +$16.1K ﹤0.01% 1199
2026
Q1 		$17.8K Sell
69
-133
-66% -$35.4K ﹤0.01% 1507
2025
Q4 		$49.8K Buy
202
+134
+197% +$28.2K ﹤0.01% 1084
2025
Q3 		$12K Sell
68
-2
-3% -$299 ﹤0.01% 1689
2025
Q2 		$9.62K Sell
70
-1
-1% -$147 ﹤0.01% 1723
2025
Q1 		$12.8K Sell
71
-48
-40% -$8.07K ﹤0.01% 1505
2024
Q4 		$18.6K Buy
+119
New +$21.1K ﹤0.01% 1386

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SBI Securities's KRYS Position: Q2 2026 in Review

SBI Securities increased its Krystal Biotech (KRYS) stake by 78% in Q2 2026, buying an estimated $16.1K and bringing the position to 123 shares worth $45.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1199.

SBI Securities first reported a position in KRYS in Q4 2024 and has held it in 7 quarters since. The position peaked at $49.8K in Q4 2025. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • SBI Securities held 123 shares of Krystal Biotech worth $45.7K as of Q2 2026.
  • SBI Securities bought 54 Krystal Biotech shares in Q2 2026, an estimated $16.1K.
  • Krystal Biotech made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1199 holding.
  • SBI Securities first reported a position in Krystal Biotech in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Krystal Biotech position peaked at $49.8K in Q4 2025.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.